| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $8,444,437 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R35GM156952 | Gene regulatory network plasticity in social behavior | 000 | 1 | NIH | 1/6/2025 | $365,000 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG066724 | Novel gastrocnemius muscle characteristics in peripheral artery disease patients associated with impaired functional performance | 001 | 5 | NIH | 11/28/2024 | $272,549 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01ES033767 | Phthalate-Induced Dysregulation of Prostaglandin and Angiogenic Function During Ovulation in Women | 000 | 4 | NIH | 11/5/2024 | $442,197 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21HD117520 | Evaluating causes for failure to thrive in a Noonan-like syndrome with loose anagen hair (NSLH) patients using NSLH vertebrate model | 000 | 1 | NIH | 11/5/2024 | $231,000 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | G08LM014412 | DASH-ing to Heart Health: Supporting Low-Income African American Women with an Interactive "Meals that Heal" Resource Book | 000 | 2 | NIH | 12/11/2024 | $239,984 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01ES032396 | A university-community partnership to reduce exposure to disinfection byproducts in Appalachia | 000 | 5 | NIH | 12/9/2024 | $102,458 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R37CA278989 | Mechanistic and structural insights into a new pro-metastatic collagen glucosyltransferase | 000 | 2 | NIH | 1/6/2025 | $461,637 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01HL172844 | Mechanisms of Thrombosis in SARS CoV-2 Infection | 000 | 1 | NIH | 1/10/2025 | $503,637 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R03EB037115 | In situ forming implant drug delivery for non-addictive post-operative analgesia | 000 | 1 | NIH | 1/8/2025 | $75,007 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG080589 | APOE Allele Switching as a Therapeutic Approach for Alzheimer's Disease | 000 | 3 | NIH | 11/22/2024 | $578,038 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R25ES027684 | Summer Research in Environmental Health Sciences | 000 | 8 | NIH | 11/22/2024 | $9,154 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K01HL149984 | Pharmacological Mechanistic Insights into Thoracic Aortic Aneurysm | 000 | 5 | NIH | 11/29/2024 | $162,000 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | F31HL170972 | Bilirubin Catabolism induces Plasminogen-Activator Inhibitor 1 (PAI-1) worsening Metabolic Dysfunction | 000 | 2 | NIH | 12/5/2024 | $34,966 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | F31HL175979 | PPARgamma Coregulators in Rosiglitazone-Induced Cardiovascular Disease | 000 | 1 | NIH | 12/5/2024 | $34,896 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | F31HL175979 | PPARgamma Coregulators in Rosiglitazone-Induced Cardiovascular Disease | 001 | 1 | NIH | 12/5/2024 | $0 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | UH3DE032621 | Empowering dentists to reduce opioid prescriptions to young people | 000 | 3 | NIH | 12/12/2024 | $947,152 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG082142 | MicroRNA lipid-nanoparticle based therapy targets neuroinflammation and ApoE dysregulation in Alzheimer’s disease | 000 | 3 | NIH | 12/6/2024 | $600,292 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K99AG084892 | Gabapentin prescription and health-related outcomes in older adults | 000 | 2 | NIH | 11/27/2024 | $89,895 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21AI180274 | Molecular mechanisms of Helicobacter pylori trans-kingdom DNA conjugation | 000 | 2 | NIH | 11/27/2024 | $172,539 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R00AR081367 | Contribution of ribosome specialization to the pathophysiology of muscular dystrophy | 000 | 4 | NIH | 11/8/2024 | $221,534 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | P20GM121327 | University of Kentucky Center for Cancer Metabolism | 001 | 9 | NIH | 12/23/2024 | $2,060,688 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01NS116068 | Macrophage Depletion Therapy for Spinal Cord Injury | 000 | 5 | NIH | 11/13/2024 | $555,534 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R13AI129382 | Autumn Immunology Conference | 000 | 7 | NIH | 11/13/2024 | $9,000 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21NS135089 | Cannabidiol (CBD) as a Potential Therapeutic for Experimental Subarachnoid Hemorrhage | 000 | 2 | NIH | 11/15/2024 | $191,250 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG070830 | Contributions of astrocyte RelA signaling in aging-related neurodegenerative sequelae following TBI | 000 | 5 | NIH | 12/19/2024 | $598,802 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01HL166225 | Targeting smooth muscle cell BMAL1 as a new therapeutic strategy against restenosis | 000 | 3 | NIH | 12/9/2024 | $598,473 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | F31DA057812 | Role of Dynamic Signaling of NRG3-ErbB4 in the Prefrontal Cortex in Mediating Nicotine Withdrawal Phenotypes | 000 | 2 | NIH | 12/13/2024 | $48,974 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DA053070 | Functional and Genomic Signatures of Escalated Fentanyl Use | 000 | 5 | NIH | 12/19/2024 | $572,466 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K01DK128022 | Elucidating Molecular Mechanisms Linking Fructose to Cholesterol Metabolism | 000 | 4 | NIH | 12/20/2024 | $148,186 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K08DK124566 | Muscle bone interaction and its role in diabetic bone disease of Type I diabetes | 000 | 5 | NIH | 12/20/2024 | $164,517 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01HL173026 | Investigating the Role of HDL-Associated Serum Amyloid A in Sepsis-Induced Acute Lung Injury and Mortality | 000 | 1 | NIH | 12/30/2024 | $699,385 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R21ES036036 | R21-UKY East Palestine Train Derailment Health Tracking Study | 000 | 2 | NIH | 12/30/2024 | $196,666 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AI155545 | Anti-inflammatory functions for non-transcriptional IRF3 | 000 | 4 | NIH | 1/3/2025 | $407,851 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | F31DA055445 | Claustrum serotonin and spike-timing plasticity associated with cognitive deficits after cocaine | 000 | 2 | NIH | 10/16/2024 | $37,511 |
| | 2025 | 2025 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K01HL177045 | Circadian Regulation of Cardiomyocyte Size and Function | 000 | 1 | NIH | 12/30/2024 | $143,829 |
| | 2025 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | T2653690 | Opioid-Impacted Family Support Program | 03 | 1 | HRSA | 1/8/2025 | $0 |
| | 2025 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | T2653690 | Opioid-Impacted Family Support Program | 01 | 1 | HRSA | 11/6/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | P1053744 | Rural Health Network Development Planning Grant Program | 01 | 1 | HRSA | 11/8/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | K99CA277245 | Reducing Lung Cancer Risk among Appalachian Women Using Community‐Engaged Intervention Research | 001 | 2 | NIH | 10/10/2024 | -$103,941 |
| | 2025 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R13DC016831 | International Society for Neurogastronomy Symposium | 003 | 7 | NIH | 10/10/2024 | $92,874 |
| | 2025 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DK124619 | Role of Hypothalamic MC4R in Glucose Homeostasis via a Novel Neuroendocrine Circuit involving the Kidneys and Adrenal Glands | 002 | 4 | NIH | 10/22/2024 | $162,163 |
| | 2025 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DK124619 | Role of Hypothalamic MC4R in Glucose Homeostasis via a Novel Neuroendocrine Circuit involving the Kidneys and Adrenal Glands | 002 | 4 | NIH | 10/22/2024 | $147,075 |
| | 2025 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R35GM136295 | Mechanisms and functions of Shoc2-transduced cellular signals | 000 | 5 | NIH | 11/4/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01DA061996 | Optimizing PrEP Care Delivery through Adaptive Intervention Strategies for Underserved Rural People who Inject Drugs | 000 | 1 | NIH | 10/29/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01AG066724 | Novel gastrocnemius muscle characteristics in peripheral artery disease patients associated with impaired functional performance | 000 | 4 | NIH | 10/25/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R00DE031825 | The Role of SoxE Transcription Factors in Neural Crest Cell Specialization | 000 | 3 | NIH | 10/23/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R03DA061626 | Neuroimmune and Cognitive Consequences of Nicotine Use in a Rodent Model of HIV: Implications for Anti-Retroviral Therapies | 000 | 1 | NIH | 10/18/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | R01MH134859 | Neural Mechanisms of Menstrual Cycle Effects on ADHD and Cognition | 000 | 1 | NIH | 10/23/2024 | $0 |
| | 2025 | 2024 | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, THE | 500 S LIMESTONE | LEXINGTON | KY | 40526-0001 | FAYETTE | USA | F32HD112067 | Establishing the Relationship Between Muscle Quality and Joint Loading for Individuals with Transtibial Amputation | 001 | 2 | NIH | 11/5/2024 | $0 |
|
